BUGATTI, Antonella
 Distribuzione geografica
Continente #
NA - Nord America 5.434
EU - Europa 4.150
AS - Asia 2.604
SA - Sud America 468
AF - Africa 74
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.758
Nazione #
US - Stati Uniti d'America 5.334
PL - Polonia 2.455
CN - Cina 909
SG - Singapore 809
UA - Ucraina 405
BR - Brasile 390
DE - Germania 293
HK - Hong Kong 260
VN - Vietnam 248
IT - Italia 226
FI - Finlandia 197
GB - Regno Unito 139
FR - Francia 119
TR - Turchia 88
RU - Federazione Russa 84
IE - Irlanda 76
IN - India 73
CA - Canada 61
BD - Bangladesh 43
ID - Indonesia 36
SE - Svezia 28
MX - Messico 24
IQ - Iraq 23
ZA - Sudafrica 23
AR - Argentina 22
AU - Australia 21
CZ - Repubblica Ceca 19
ES - Italia 19
JP - Giappone 17
AT - Austria 16
NL - Olanda 16
EC - Ecuador 12
VE - Venezuela 12
BE - Belgio 11
CL - Cile 10
NG - Nigeria 10
PK - Pakistan 10
SA - Arabia Saudita 10
PE - Perù 9
UZ - Uzbekistan 9
EG - Egitto 8
JO - Giordania 8
KE - Kenya 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 6
EU - Europa 6
LT - Lituania 6
PT - Portogallo 6
AZ - Azerbaigian 5
CH - Svizzera 5
KZ - Kazakistan 5
LK - Sri Lanka 5
OM - Oman 5
TN - Tunisia 5
TW - Taiwan 5
UY - Uruguay 5
BG - Bulgaria 4
CO - Colombia 4
IR - Iran 4
JM - Giamaica 4
MD - Moldavia 4
MY - Malesia 4
NP - Nepal 4
CR - Costa Rica 3
DK - Danimarca 3
HR - Croazia 3
KG - Kirghizistan 3
KR - Corea 3
PA - Panama 3
PS - Palestinian Territory 3
PY - Paraguay 3
TH - Thailandia 3
AL - Albania 2
PH - Filippine 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KW - Kuwait 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
NO - Norvegia 1
RW - Ruanda 1
SI - Slovenia 1
SV - El Salvador 1
TC - Turks e Caicos 1
Totale 12.757
Città #
Warsaw 2.452
Ashburn 562
Fairfield 549
Singapore 426
Woodbridge 325
Houston 303
Jacksonville 282
Hong Kong 259
San Jose 253
Chandler 235
Cambridge 221
Seattle 216
Beijing 210
Wilmington 195
Ann Arbor 191
Dallas 175
The Dalles 171
New York 149
Princeton 131
Helsinki 122
Los Angeles 109
Dong Ket 87
Nanjing 84
Brescia 77
Dublin 75
Council Bluffs 73
Munich 70
Istanbul 69
Lauterbourg 65
Ho Chi Minh City 58
Jinan 42
Porto Alegre 41
Shanghai 39
Nanchang 37
San Francisco 37
São Paulo 35
Boardman 32
Des Moines 32
Dearborn 30
Changsha 29
San Diego 29
Hebei 28
Shenyang 27
Hanoi 26
Redondo Beach 26
Buffalo 25
Phoenix 25
Santa Clara 25
Chicago 24
Jakarta 24
Orem 24
Toronto 24
Milan 22
Tianjin 22
Hangzhou 21
London 21
Moscow 20
Johannesburg 19
Atlanta 18
Jiaxing 18
Stockholm 18
Turku 18
Guangzhou 16
Brooklyn 15
Denver 15
Manchester 15
Parma 15
Tokyo 15
Brno 14
Lancaster 14
Zhengzhou 14
Charlotte 13
Montreal 13
Chennai 12
Haikou 12
Boston 11
Frankfurt am Main 11
Nuremberg 11
Abuja 10
Rio de Janeiro 10
Verona 10
Amsterdam 9
Lanzhou 9
Mumbai 9
Brussels 8
Kilburn 8
Kunming 8
Mexico City 8
Salt Lake City 8
Tashkent 8
Vancouver 8
Amman 7
Baghdad 7
Belo Horizonte 7
Curitiba 7
Norwalk 7
Taiyuan 7
Augusta 6
Caxias do Sul 6
Erbil 6
Totale 9.441
Nome #
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Epheephrin system 371
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 363
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 323
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 319
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 316
Biological role of immunoglobulin Free light chains interactomes 310
Membrane association of peroxiredoxin-2 in red cells is mediated by n-terminal cytoplasmic domain of band 3 309
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the development of multitarget inhibitors of extracellular Tat 308
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 301
Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands 292
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 286
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 284
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 272
Pradamicin A: a new therapeutic concept for tretment of virus infections with a glycosilated envelope such as human immunodeficiency virus 261
Inhibition of Non Canonical HIV-1 Tat Secretion Through the Cellular Na+,K+-ATPase Blocks HIV-1 Infection 260
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors 258
A complex of α(6) integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. 247
The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice 244
Functionalization of gold surfaces with copoly(DMA-NAS-MAPS) by dip coating: Surface characterization and hybridization tests 232
Chemoselective surface immbolization of proteins through a cleavable peptide 224
The agmatine-containing poly(Amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents attachment of mucosal human papillomaviruses 221
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 220
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 217
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 203
Merging colloidal nanoplasmonics and surface plasmon resonance spectroscopy for enhanced profiling of multiple myeloma-derived exosomes 191
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 180
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 177
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 176
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 171
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 166
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual 166
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 158
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 153
Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model. 150
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells 149
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 148
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 147
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 145
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 144
Plasmonic exosomes for enhanced monitoring of monoclonal gammopathies 144
The synthetic dipeptide pidotimod shows a chemokine-like activity through cxc chemokine receptor 3 (Cxcr3) 134
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 132
Sulfated K5 Escherichia coli polysaccharide derivatives as wide range inhibitors of genital types of human papillomavirus 131
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding Peptide. 126
Surface plasmon resonance analysis of heparin-binding angiogenic growth factors 126
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques 123
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 123
Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule. 122
Positively charged peptides can interact with each other as revealed by solid phase binding assays 119
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 119
Methotrexate inhibits SARS-CoV-2 virus replication “in vitro” 119
Peptide-Derivatized SB105-A10 Dendrimer Inhibits the Infectivity of R5 and X4 HIV-1 Strains in Primary PBMCs and Cervicovaginal Histocultures 118
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation 114
Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses 112
EXPLOTING SURFACE PLASMON RESONANCE (SPR) TECHNOLOGY FOR THE IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-2 (FGF2) ANTAGONISTS ENDOWED WITH ANTI-ANGIOGENIC ACTIVITY 109
FGF2- Antagonist activity of long pentraxin-3 109
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin 109
FGF2-Antagonist activity of long pentraxin-3 related peptides 107
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 107
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide 103
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 101
Role of autophagy in von willebrand factor secretion by endothelial cells and in the in vivo thrombin-antithrombin complex formation promoted by the hiv-1 matrix protein p17 99
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 90
The NLS of the HIV-1 Tat protein interacts with the fd bacteriophage and with a peptide derived from its p8 protein 87
Human Metapneumovirus Establishes Persistent Infection in Lung Microvascular Endothelial Cells and Primes a Th2-Skewed Immune Response 84
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 84
Identification of an anti-angiogenic FGF2-binding site in the n-terminal extension of the soluble pattern recognition receptor long-pentraxin PTX3 81
exploiting surface plasmon resonance technology for the identification of fibroblast growth factor 2 (FGF2) antagonists endowed with antiangiogenic activity 80
inhibition of intra- and extra-cellular Tat function and HIV expression by pertussin toxin B-oligomer 78
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort 78
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 77
development of novel small molecules mimicking thrombospondin-1 (TSP-1) antiangiogenic activity 74
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 73
Emergence of S gene-based quasispecies explains an optimal adaptation of Omicron BA.5 subvariant in the immunocompetent vaccinated human host 72
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 61
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions 49
A Dynamic and Effective Peptide-Based Strategy for Promptly Addressing Emerging SARS-CoV-2 Variants of Concern 27
A broad-spectrum anti-angiogenic tetrapeptide regresses diabetic retinopathy through β-arrestin-1 binding and prevention of Akt phosphorylation 26
Molecular mechanisms behind the generation of pro-oncogenic HIV-1 matrix protein p17 variants 17
Heparan sulfate proteoglycans remodel SARS-CoV-2 spike conformation to allow integrin interaction and infection of endothelial cells 12
Totale 12.918
Categoria #
all - tutte 52.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021123 0 0 0 0 0 0 0 0 0 0 0 123
2021/2022627 37 147 15 18 16 15 32 46 33 72 59 137
2022/2023565 75 30 22 35 52 136 2 77 85 3 28 20
2023/2024699 44 10 61 39 42 116 31 27 152 28 31 118
2024/20251.384 15 9 11 226 108 119 78 61 154 136 275 192
2025/20263.398 249 354 340 474 327 242 535 147 202 324 94 110
Totale 12.918